Exsilio Therapeutics

CEO - Tal Zaks
CEO - Tal Zaks
USA | Funding: $82M (+)

Website: https://exsiliotx.com

Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.